Pharmacological Potential of Inonotus Obliquus: An Integrative Review of Antitumour, Immunomodulatory and Anti-Inflammatory Effects

Keywords: Chaga mushroom, Inonotus obliquus, Antitumour effects, Anti-inflammatory agents, Phytochemicals, Biological products, Pharmacology

Abstract


Inonotus obliquus (Chaga mushroom), long used in traditional medicine, has recently gained substantial scientific attention due to its diverse pharmacological activities. While numerous preclinical studies exist, the lack of a comprehensive understanding of its molecular mechanisms continues to hinder clinical translation. This review summarises current evidence on the antitumour, immunomodulatory, anti-inflammatory and antioxidant effects of I obliquus, with emphasis on the underlying cellular pathways. The pharmacological activity of Chaga is mediated by a complex array of bioactive compounds that collectively induce apoptosis and cell-cycle arrest in cancer cells, modulate the complement system, suppress pro-inflammatory mediators in macrophages and enhance antioxidant defence mechanisms. These effects result from multifactorial and often synergistic interactions with key signalling cascades, including nuclear factor-kappa B (NF-kB), mitogen-activated protein kinase (MAPK) and PI3K/Akt pathways. Although experimental data are promising, the translation of I obliquus from a traditional remedy into standardised therapeutic formulations is constrained by chemical variability and a lack of robust clinical validation. Continued multidisciplinary research is essential to elucidate its pharmacological potential and to position Chaga as a valuable source of novel therapeutic agents in modern medicine.             

Author Biographies

Daniella Osipova, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

Student at I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

Asiyat Shakhbanova, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

Student at I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

Alina Yunusova, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

Student at I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

Shakhban Shakhbanov, A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia

Student at A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia

Leyla Alieva, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

Student at I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

Polina Skovorodko , I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

pHD Researcher at I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

 

Mike Parshenkov, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

Researcher at  I.M. Sechenov First Moscow State Medical University (Sechenov University)

References

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024 May-Jun;74(3):229–63. doi: 10.3322/caac.21834.

Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025 Jan-Feb;75(1):10–45. doi: 10.3322/caac.21871.

Pahwa R, Goyal A, Jialal I. Chronic inflammation. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. PMID:29630225.

Kumar Karn S, Zhao F, Xu Y, Zhang Y, Zeng C, et al. Metabolic syndrome with mortality and major adverse cardiovascular events in an elderly population. Front Endocrinol (Lausanne). 2025 May 22;16:1570191. doi: 10.3389/fendo.2025.1570191.

Donkor ES. Stroke in the 21st century: a snapshot of the burden, epidemiology, and quality of life. Stroke Res Treat. 2018;2018:3238165. doi: 10.1155/2018/3238165.

Miller FW. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Curr Opin Immunol. 2023 Feb;80:102266. doi: 10.1016/j.coi.2022.102266.

Zafar A, Khatoon S, Khan MJ, Abu J, Naeem A. Advancements and limitations in traditional anti cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy. Discov Oncol. 2025 Apr 24;16(1):607. doi: 10.1007/s12672-025-02198-8.

Lee MW, Hur H, Chang KC, Lee TS, Ka KH, Jankovsky L. Introduction to distribution and ecology of sterile conks of Inonotus obliquus. Mycobiology. 2008;36:199–202. doi: 10.4489/MYCO.2008.36.4.199.

Niu H, Song D, Mu H, Zhang W, Sun F, Duan J. Investigation of three lignin complexes with antioxidant and immunological capacities from Inonotus obliquus. Int J Biol Macromol. 2016;86:587–93. doi: 10.1016/j.ijbiomac.2016.01.111.

Camilleri E, Blundell R, Baral B, Karpinski TM, Aruci E, Atrooz OM. A brief overview of the medicinal and nutraceutical importance of Inonotus obliquus (chaga) mushrooms. Heliyon. 2024 Aug 6;10(15):e35638. doi: 10.1016/j.heliyon.2024.e35638.

Ern PTY, Quan TY, Yee FS, Yin ACY. Therapeutic properties of Inonotus obliquus (Chaga mushroom): a review. Mycology. 2023 Oct 20;15(2):144–161. doi: 10.1080/21501203.2023.2260408.

Pinar O, Rodríguez Couto S. Biologically active secondary metabolites from white rot fungi. Front Chem. 2024 Mar 13;12:1363354. doi: 10.3389/fchem.2024.1363354.

Yeo D, Yun YG, Shin SJ, et al. Chaga mushroom extract suppresses oral cancer cell growth via inhibition of energy metabolism. Sci Rep. 2024;14:10616. doi: 10.1038/s41598-024-61125-z.

Raal A, Kaldmäe H, Kütt K, Jürimaa K, Silm M, Bleive U, et al. Chemical content and cytotoxic activity on various cancer cell lines of Chaga (Inonotus obliquus) growing on Betula pendula and Betula pubescens. Pharmaceuticals (Basel). 2024 Aug 1;17(8):1013. doi: 10.3390/ph17081013.

Plehn S, Wagle S, Rupasinghe HPV. Chaga mushroom triterpenoids as adjuncts to minimally invasive cancer therapies: a review. Curr Res Toxicol. 2023 Nov 15;5:100137. doi: 10.1016/j.crtox.2023.100137.

Szychowski KA, Skóra B, Pomianek T, Gmiński J. Inonotus obliquus—from folk medicine to clinical use. J Tradit Complement Med. 2020 Aug 22;11(4):293–302. doi: 10.1016/j.jtcme.2020.08.003.

Windsor C, Kreynes AE, Chilton JS, Chioffi WA, Krishnamurthy A, Ishii M. Comparative study of Chaga (Inonotus obliquus) dietary supplements using complementary analytical techniques. Int J Mol Sci. 2025 Mar 25;26(7):2970. doi: 10.3390/ijms26072970.

Chen YY, Gu XH, Huang SQ, Li JW, Wang X, Tang J. Optimization of ultrasonic/microwave assisted extraction (UMAE) of polysaccharides from Inonotus obliquus and evaluation of its anti tumor activities. Int J Biol Macromol. 2010;46:429–35. doi: 10.1016/j.ijbiomac.2010.02.003.

Zheng W, Miao K, Liu Y, Zhao Y, Zhang M, Pan S, Dai Y. Chemical diversity of biologically active metabolites in the sclerotia of Inonotus obliquus and submerged culture strategies for up regulating their production. Appl Microbiol Biotechnol. 2010;87:1237–54. doi: 10.1007/s00253-010-2682-4.

Khabibrakhmanova VR, Nikitina SA, Sysoeva MA. Study of aqueous extracts of Chaga. XIV. Quantitative and qualitative composition of lipid substances of aqueous extract of Chaga. Bull Kazan Technol Univ. 2012;15(18):217–9.

Zhao YX, Zheng WF. Deciphering the antitumoral potential of the bioactive metabolites from medicinal mushroom Inonotus obliquus. J Ethnopharmacol. 2021;265:113321. doi: 10.1016/j.jep.2020.113321.

Yu J, Xiang HY, Xie QH. The difference of regulatory effect of two Inonotus obliquus extracts on high fat diet mice in relation to the fatty acid elongation function of gut microbiota. Food Sci Nutr. 2021;9:449–58. doi: 10.1002/fsn3.2012.

Tanye X. Optimization of extraction of polysaccharides from Inonotus obliquus by response surface methodology and antioxidant activity. Food Res Dev. 2021;42:143–8.

Lu XH, Wang MY, Zhao ZZ, Hu JR, Zhang JS, Liu P. Effect of different pretreatment of birch sawdust on the production of active polysaccharides by Inonotus obliquus under submerged fermentation and its structural mechanism. Appl Biochem Biotechnol. 2021:1–13. doi: 10.1007/s12010-021-03508-w.

Wang Y, Ouyang F, Teng C, Qu J. Optimization for the extraction of polyphenols from Inonotus obliquus and its antioxidation activity. Prep Biochem Biotechnol. 2020. doi: 10.1080/10826068.2020.186464.

Du N, Wu K, Zhang J, Wang L, Pan X, Zhu Y, et al. Inonotsuoxide B regulates M1 to M2 macrophage polarization through sirtuin 1/endoplasmic reticulum stress axis. Int Immunopharmacol. 2021;96:107603. doi: 10.1016/j.intimp.2021.107603.

Maza PAMA, Lee JH, Kim YS, Sun GM, Sung YJ, Ponomarenko LP, et al. Inotodiol from Inonotus obliquus Chaga mushroom induces atypical maturation in dendritic cells. Front Immunol. 2021;12:650841. doi: 10.3389/fimmu.2021.650841.

Zou CX, Dong SH, Hou ZL, Yao GD, Lin B, Huang XX, Song SJ. Modified lanostane type triterpenoids with neuroprotective effects from the fungus Inonotus obliquus. Bioorg Chem. 2020;105:104438. doi: 10.1016/j.bioorg.2020.104438.

Teplyakova TV, Ilyicheva TN, Markovich NA. Prospects for the development of anti influenza drugs based on medicinal mushrooms (review). Appl Biochem Microbiol. 2020;56:489–96. doi: 10.1134/S0003683820050142.

Sysoeva MA, Khabibrakhmanova VR, Urazlina LN. Nutrient medium for cultivation of Chaga fungus. RU2019124646. 2019 Jul 31.

Park J, Nguyen TMN, Park HA, Nguyen MTT, Lee NY, Ban SY, et al. Protective effects of lanostane triterpenoids from Chaga mushroom in human keratinocytes, HaCaT cells, against inflammatory and oxidative stresses. Int J Mol Sci. 2023 Aug 15;24(16):12803. doi: 10.3390/ijms241612803.

Wang J, Beghelli D, Amici A, Sut S, Dall’Acqua S, Lupidi G, et al. Chaga mushroom triterpenoids inhibit dihydrofolate reductase and act synergistically with conventional therapies in breast cancer. Biomolecules. 2024;14(11):1454. doi: 10.3390/biom14111454.

Shen D, Feng Y, Zhang X, Liu J, Gong L, Liao H, Li R. In vitro immunomodulatory effects of Inonotus obliquus extracts on resting M0 macrophages and LPS induced M1 macrophages. Evid Based Complement Alternat Med. 2022;2022:8251344. doi: 10.1155/2022/8251344.

Fordjour E, Manful CF, Javed R, Galagedara LW, Cuss CW, Cheema M, Thomas R. Chaga mushroom: a super fungus with countless facets and untapped potential. Front Pharmacol. 2023 Dec 5;14:1273786. doi: 10.3389/fphar.2023.1273786.

Wold CW, Christopoulos PF, Arias MA, Dzovor DE, Øynebråten I, Corthay A, Inngjerdingen KT. Fungal polysaccharides from Inonotus obliquus are agonists for Toll like receptors and induce macrophage anti cancer activity. Commun Biol. 2024 Feb 23;7(1):222. doi: 10.1038/s42003-024-05853-y.

Alhallaf W, Perkins LB. The anti inflammatory properties of Chaga extracts obtained by different extraction methods against LPS induced RAW 264.7. Molecules. 2022 Jun 30;27(13):4207. doi: 10.3390/molecules27134207.

Sang R, Sun F, Zhou H, Wang M, Li H, Li C, et al. Immunomodulatory effects of Inonotus obliquus polysaccharide on splenic lymphocytes infected with Toxoplasma gondii via NF κB and MAPKs pathways. Immunopharmacol Immunotoxicol. 2022 Feb;44(1):129–38. doi: 10.1080/08923973.2021.2017453.

Abugomaa A, Elbadawy M, Ishihara Y, Yamamoto H, Kaneda M, Yamawaki H, et al. Anti cancer activity of Chaga mushroom (Inonotus obliquus) against dog bladder cancer organoids. Front Pharmacol. 2023 Apr 19;14:1159516. doi: 10.3389/fphar.2023.1159516.

Hao R, Li Y, Shan S, Xu H, Li J, Li Z, Li R. Antioxidant potential of styrene pyrone polyphenols from Inonotus obliquus: a combined experimental, density functional theory (DFT) approach and molecular dynamic (MD) simulation. J Saudi Chem Soc. 2023;27(4):101652. doi: 10.1016/j.jscs.2023.101652.

Burczyk J, Gawron A, Slotwinska M, Smietana B, Terminska K. Antimitotic activity of aqueous extracts of Inonotus obliquus. Boll Chim Farm. 1996 May;135(5):306-9. PMID: 8942059.

Rzymowska J. The effect of aqueous extracts from Inonotus obliquus on the mitotic index and enzyme activities. Boll Chim Farm. 1998 Jan;137(1):13-5. PMID: 9595828.

Yan ZF, Yang Y, Tian FH, Mao XX, Li Y, Li CT. Inhibitory and acceleratory effects of Inonotus obliquus on tyrosinase activity and melanin formation in B16 melanoma cells. Evid Based Complement Alternat Med. 2014;2014:259836. doi: 10.1155/2014/259836.

Kim YO, Park HW, Kim JH, Lee JY, Moon SH, Shin CS. Anti-cancer effect and structural characterization of endo-polysaccharide from cultivated mycelia of Inonotus obliquus. Life Sci. 2006 May 30;79(1):72-80. doi: 10.1016/j.lfs.2005.12.047.

Kang JH, Jang JE, Mishra SK, Lee HJ, Nho CW, Shin D, et al. Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti cancer activity by down regulation of the β catenin pathway in colorectal cancer. J Ethnopharmacol. 2015 Sep 15;173:303–12. doi: 10.1016/j.jep.2015.07.030.

Youn MJ, Kim JK, Park SY, Kim Y, Kim SJ, Lee JS, et al. Chaga mushroom (Inonotus obliquus) induces G0/G1 arrest and apoptosis in human hepatoma HepG2 cells. World J Gastroenterol. 2008 Jan 28;14(4):511–517. doi: 10.3748/wjg.14.511.

Baek J, Roh HS, Baek KH, Lee S, Lee S, Song SS, Kim KH. Bioactivity based analysis and chemical characterization of cytotoxic constituents from Chaga mushroom (Inonotus obliquus) that induce apoptosis in human lung adenocarcinoma cells. J Ethnopharmacol. 2018 Oct 5;224:63–75. doi: 10.1016/j.jep.2018.05.025.

Islam MA, Hossen MB, Horaira MA, Hossen MA, Kibria MK, Reza MS, et al. Exploring core genes by comparative transcriptomics analysis for early diagnosis, prognosis, and therapies of colorectal cancer. Cancers (Basel). 2023 Feb 21;15(5):1369. doi: 10.3390/cancers15051369.

Sharma A, Yadav D, Rao P, Sinha S, Goswami D, Rawal RM, et al. Identification of potential therapeutic targets associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis. Comput Biol Med. 2022 Jul;146:105688. doi: 10.1016/j.compbiomed.2022.105688.

Fakhri S, Moradi SZ, Farzaei MH, Bishayee A. Modulation of dysregulated cancer metabolism by plant secondary metabolites: a mechanistic review. Semin Cancer Biol. 2022 May;80:276–305. doi: 10.1016/j.semcancer.2020.02.007.

Wang R, Lan C, Benlagha K, Camara NOS, Miller H, Kubo M, et al. The interaction of innate immune and adaptive immune system. MedComm (2020). 2024 Sep 15;5(10):e714. doi: 10.1002/mco2.714.

Carpenter S, O'Neill LAJ. From periphery to center stage: 50 years of advancements in innate immunity. Cell. 2024 Apr 25;187(9):2030–2051. doi: 10.1016/j.cell.2024.10.013.

Wold CW, Gerwick WH, Wangensteen H, Inngjerdingen KT. Bioactive triterpenoids and water soluble melanin from Inonotus obliquus (Chaga) with immunomodulatory activity. J Funct Foods. 2020;71:104025. doi: 10.1016/j.jff.2020.104025.

Zhang L, Fei Z, Ding Y, Zhang Y, Ding Z, Huang Y, et al. Inonotus obliquus fermentation product improves growth performance and meat quality probably through intestine and antioxidant capacity enhanced by gut microbes and metabolites regulation in rabbits. Anim Microbiome. 2025 Jun 9;7(1):61. doi: 10.1186/s42523-025-00427-7.

Lee YS, Olefsky J. Chronic tissue inflammation and metabolic disease. Genes Dev. 2021 Mar 1;35(5 6):307–28. doi: 10.1101/gad.346312.120.

Chen S, Saeed AFUH, Liu Q, Jiang Q, Xu H, Xiao GG, et al. Macrophages in immunoregulation and therapeutics. Signal Transduct Target Ther. 2023 May 22;8(1):207. doi: 10.1038/s41392-023-01452-1.

Lively S, Schlichter LC. Microglia responses to pro inflammatory stimuli (LPS, IFNγ+TNFα) and reprogramming by resolving cytokines (IL 4, IL 10). Front Cell Neurosci. 2018 Jul 24;12:215. doi: 10.3389/fncel.2018.00215.

Strizova Z, Benesova I, Bartolini R, Novysedlak R, Cecrdlova E, Foley LK, et al. M1/M2 macrophages and their overlaps—myth or reality? Clin Sci (Lond). 2023 Aug 14;137(15):1067–93. doi: 10.1042/CS20220531.

Kim ME, Lee JS. Advances in the regulation of inflammatory mediators in nitric oxide synthase: implications for disease modulation and therapeutic approaches. Int J Mol Sci. 2025 Jan 30;26(3):1204. doi: 10.3390/ijms26031204.

Fu Y, Jiang T, Fang X, Chen Y, Li J, Huang S, et al. Integrating network pharmacology and experimental validation to explore the effect and mechanism of Inonotus obliquus polysaccharide in the treatment of rheumatoid arthritis. Pharmaceuticals (Basel). 2025 Jul 8;18(7):1017. doi: 10.3390/ph18071017.

Peng Y, Zhang Y, Wang R, Wang X, Liu X, Liao H, Li R. Inonotus obliquus (chaga) ameliorates folic acid‑induced renal fibrosis in mice: the crosstalk analysis among PT cells, macrophages and T cells based on single‑cell sequencing. Front Pharmacol. 2025;16:1556739. doi: 10.3389/fphar.2025.1556739.

Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V, Squadrito F, Altavilla D, Bitto A. Oxidative stress: harms and benefits for human health. Oxid Med Cell Longev. 2017;2017:8416763. doi: 10.1155/2017/8416763.

Parshenkov MA, Skovorodko PP, Petrusevich DA, Makaeva SN, Osipova SG, Ibragimova G, et al. Bio‑synthetic potential of Inonotus obliquus in symbiosis with bacterial cellulose: optimisation and prospects. Scr Med. 2025 Mar‑Apr;56(2):221–31. doi: 10.5937/scriptamed56-57436.

D’Elia M, Marino C, Celano R, Napolitano E, Colarusso C, Sorrentino R, et al. Impact of a formulation containing chaga extract, coenzyme Q10, and alpha‑lipoic acid on mitochondrial dysfunction and oxidative stress: NMR metabolomic insights into cellular energy. Antioxidants (Basel). 2025;14(6):753. doi: 10.3390/antiox14060753.

Wu Y, Liu J, Luo J, Xu B. Molecular mechanisms of phytochemicals from chaga mushroom (Inonotus obliquus) against colorectal cancer: insights from network pharmacology, molecular docking, and bioinformatics. Int J Mol Sci. 2025 Aug 8;26(16):7664. doi: 10.3390/ijms26167664.

Published
2026/02/28
Section
Review article